La revue scientifique trimestrielle

19/02/2024

Leveraging CHO cell potential in R&D and cGMP

  • Cell banking
  • cell banks
  • Characterization
  • CHO cell
  • Clonal Selection
  • GMP
  • manufacturing
  • R&D
  • Single Cell Cloning
  • Storage

With 25 years of experience handling hundreds of cell lines, Clean Cells is your reliable partner on both adherent and suspension models with cloning and manufacturing technologies for CHO cell lines. Our extensive portfolio of QC assays also ensures the best level of characterization for the most potent and safe CHO cells, with complementary and novel methods for monoclonal antibody characterization (ADCC).

Lire la suite
24/10/2023

Increasing biologics manufacturing capacities

  • banques cellulaires
  • banques virales
  • BPF
  • Capabilities
  • Cell banking
  • cell banks
  • end-to-end
  • Facilities
  • GMP
  • manufacturing
  • starting materials
  • Working Cell Seed
  • Working Virus Seed

With 23+ years of experience handling hundreds of cell and virus models, Clean Cells has positioned itself as a leader in cell and virus banking, providing complementary characterization and storage services. Our state-of-the-art cGMP facility launched earlier this year now welcomes our biologics manufacturing capacities, providing 8 new clean rooms designed for all types of biopharma projects and equiped to meet production specifications for both adherent and suspension cells.

Lire la suite
Scale-XTM bioreactor
26/06/2023

Assessing the scale-X(TM) bioreactor’s biomanufacturing capacities on Vero cells

  • Capabilities
  • Cell banking
  • cell banks
  • Facilities
  • Naobios

To further extend their biomanufacturing capabilities and cater to Univercells clients' growing needs, Naobios has recently conducted a comprehensive assessment of the performance of Vero cells cultured within the scale-X(TM) bioreactor provided by Univercells Technologies. This assessment aimed to evaluate the compatibility and efficiency of the Vero cell line in this novel bioreactor system for viral-based bioproduction.

Lire la suite